AAV9 supports wide-scale transduction of the CNS and TDP-43 disease modeling in adult rats

Molecular Therapy Methods and Clinical Development

Volumn 2, Issue , 2015, Pages 15036-

  Jackson, Kasey L ^a   Dayton, Robert D ^a   Klein, Ronald L ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; TAR DNA BINDING PROTEIN; ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 1; ADENO ASSOCIATED VIRUS 10; ADENO ASSOCIATED VIRUS 8; ADENO ASSOCIATED VIRUS 9; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; FEMALE; MALE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEROTYPE; SIGNAL TRANSDUCTION; TDP 43 PROTEINOPATHY; VIRAL GENE DELIVERY SYSTEM; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DISEASE MODEL; GENE TRANSFER; GENETIC TRANSDUCTION; SPINAL CORD;

EID: 84978227156     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2015.36     Document Type: Article

References (29)

1. 1 Gao, G, Vandenberghe, LH, Alvira, MR, Lu, Y, Calcedo, R, Zhou, X, et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 78 (2004), 6381–6388.
2. 2 Cearley, CN, Wolfe, JH, Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 13 (2006), 528–537.
3. 3 Duque, S, Joussemet, B, Riviere, C, Marais, T, Dubreil, L, Douar, AM, et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther 17 (2009), 1187–1196.
4. 4 Foust, KD, Nurre, E, Montgomery, CL, Hernandez, A, Chan, CM, Kaspar, BK, Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27 (2009), 59–65.
5. 5 Miyake, N, Miyake, K, Yamamoto, M, Hirai, Y, Shimada, T, Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors. Brain Res 1389 (2011), 19–26.
6. 6 Foust, KD, Wang, X, McGovern, VL, Braun, L, Bevan, AK, Haidet, AM, et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28 (2010), 271–274.
7. 7 Valori, CF, Ning, K, Wyles, M, Mead, RJ, Grierson, AJ, Shaw, PJ, et al. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med, 2, 2010, 35ra42.
8. 8 Dominguez, E, Marais, T, Chatauret, N, Benkhelifa-Ziyyat, S, Duque, S, Ravassard, P, et al. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20 (2011), 681–693.
9. 9 Glascock, JJ, Shababi, M, Wetz, MJ, Krogman, MM, Lorson, CL, Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy. Biochem Biophys Res Commun 417 (2012), 376–381.
10. 10 Tsai, LK, Chen, CL, Ting, CH, Lin-Chao, S, Hwu, WL, Dodge, JC, et al. Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice. Mol Ther 22 (2014), 1450–1459.
11. 11 Meyer, K, Ferraiuolo, L, Schmelzer, L, Braun, L, McGovern, V, Likhite, S, et al. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates. Mol Ther 23 (2015), 477–487.
12. 12 Fu, H, Dirosario, J, Killedar, S, Zaraspe, K, McCarty, DM, Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery. Mol Ther 19 (2011), 1025–1033.
13. 13 Spampanato, C, De Leonibus, E, Dama, P, Gargiulo, A, Fraldi, A, Sorrentino, NC, et al. Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder. Mol Ther 19 (2011), 860–869.
14. 14 Shen, F, Kuo, R, Milon-Camus, M, Han, Z, Jiang, L, Young, WL, et al. Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci. Stroke 44 (2013), 252–254.
15. 15 Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 < https://clinicaltrials.gov/ct2/show/NCT02122952>.
16. 16 Wang, DB, Dayton, RD, Henning, PP, Cain, CD, Zhao, LR, Schrott, LM, et al. Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther 18 (2010), 2064–2074.
17. 17 Dayton, RD, Gitcho, MA, Orchard, EA, Wilson, JD, Wang, DB, Cain, CD, et al. Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis. Mol Ther 21 (2013), 1324–1334.
18. 18 Jackson, KL, Dayton, RD, Orchard, EA, Ju, S, Ringe, D, Petsko, GA, et al. Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis. Gene Ther 22 (2015), 20–28.
19. 19 Yang, B, Li, S, Wang, H, Guo, Y, Gessler, DJ, Cao, C, et al. Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10. Mol Ther 22 (2014), 1299–1309.
20. 20 Maguire, CA, Crommentuijn, MH, Mu, D, Hudry, E, Serrano-Pozo, A, Hyman, BT, et al. Mouse gender influences brain transduction by intravascularly administered AAV9. Mol Ther 21 (2013), 1470–1471.
21. 21 Davidoff, AM, Ng, CY, Zhou, J, Spence, Y, Nathwani, AC, Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood 102 (2003), 480–488.
22. 22 Dodge, JC, Clarke, J, Passini, MA, Song, A, O'Riordan, CR, Cheng, SH, et al. Sex and estrous cycle stage influence the efficiency of AAV-mediated gene transfer in the rodent brain. Abstract. Mol Ther 11 (2005), S192–S193.
23. 23 Neumann, M, Sampathu, DM, Kwong, LK, Truax, AC, Micsenyi, MC, Chou, TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006), 130–133.
24. 24 Federici, T, Taub, JS, Baum, GR, Gray, SJ, Grieger, JC, Matthews, KA, et al. Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther 19 (2012), 852–859.
25. 25 Samaranch, L, Salegio, EA, San Sebastian, W, Kells, AP, Foust, KD, Bringas, JR, et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23 (2012), 382–389.
26. 26 Passini, MA, Bu, J, Richards, AM, Treleaven, CM, Sullivan, JA, O'Riordan, CR, et al. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. Hum Gene Ther 25 (2014), 619–630.
27. 27 Guo, Y, Wang, D, Qiao, T, Yang, C, Su, Q, Gao, G, et al. A single injection of recombinant adeno-associated virus into the lumbar cistern delivers transgene expression throughout the whole spinal cord. Mol Neurobiol, 2015 (epub ahead of print).
28. 28 Klein, RL, Hamby, ME, Gong, Y, Hirko, AC, Wang, S, Hughes, JA, et al. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 176 (2002), 66–74.
29. 29 Klein, RL, Dayton, RD, Tatom, JB, Henderson, KM, Henning, PP, AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol Ther 16 (2008), 89–96.